Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Plus Therapeutics Inc (PSTV)  
$0.26 0.00 (0.00%) as of 4:30 Fri 4/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 21,110,000
Market Cap: 5.48(M)
Last Volume: 4,769,812 Avg Vol: 4,756,792
52 Week Range: $0.2598 - $0.2598
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. The clinical stage drugs in Co.'s pipeline are: Rhenium NanoLiposomes, a radiotherapy for patients with recurrent glioblastoma; DocePLUS™, a chemotherapy for patients with tumors that has been evaluated in a completed U.S. single-center Phase 1 clinical trial; and DoxoPLUS™, a generic chemotherapy that has been evaluated in a completed, bioequivalence clinical trial in the U.S., Canada, and Ukraine versus Janssen's CAELYX® in patients with ovarian cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 48,285 48,285 100,872 108,373
Total Buy Value $98,501 $98,501 $185,764 $199,106
Total People Bought 6 6 6 6
Total Buy Transactions 6 6 17 20
Total Shares Sold 0 0 2,068 3,568
Total Sell Value $0 $0 $4,053 $4,525
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 2
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 340
  Page 11 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hedrick Marc H President   •       –      –    2006-11-30 4 B $4.32 $21,600 D/D 5,000 428,238 2.74     -
   Hedrick Marc H President   •       –      –    2006-11-28 4 B $4.25 $21,262 D/D 5,000 423,238 2.74     -
   Hedrick Marc H President   •       –      –    2006-11-27 4 B $4.45 $11,125 D/D 2,500 418,238 2.74     -
   Hedrick Marc H President   •       –      –    2006-11-24 4 B $4.29 $12,870 D/D 3,000 415,738 2.74     -
   Shirahama Norio Seijiro Senior Vice President Asia Pac   •       –      –    2006-11-21 4 B $4.20 $8,400 D/D 2,000 4,200 2.74     -
   Hedrick Marc H President   •       –      –    2006-11-21 4 B $4.12 $9,120 D/D 2,213 412,738 2.74     -
   Reuter Bruce Sen. VP Intern Sales, Marketin   •       –      –    2006-11-09 3 IO $0.00 $0 D/D 0 4,193     -
   Milstein Alexander M Vice President Clinical Develo   •       –      –    2006-09-08 4 B $4.50 $900 D/D 200 1,200 2.66     -
   Milstein Alexander M Vice President Clinical Develo   •       –      –    2006-09-07 4 B $4.50 $900 D/D 200 1,000 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-09-05 4 B $5.06 $9,393 D/D 1,850 61,500 2.74     -
   Milstein Alexander M Vice President Clinical Devel   •       –      –    2006-09-05 4 B $5.10 $2,040 D/D 400 800 2.66     -
   Milstein Alexander M Vice President Clinical Devel   •       –      –    2006-09-01 4 B $5.20 $2,080 D/D 400 400 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-09-01 4 B $5.20 $8,229 D/D 1,550 59,650 2.74     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-31 4 B $5.45 $4,113 D/D 750 58,100 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-30 4 B $5.40 $4,068 D/D 750 57,350 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-29 4 B $5.16 $4,169 D/D 800 56,600 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-28 4 B $5.20 $4,158 D/D 800 55,800 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-25 4 B $4.98 $3,994 D/D 800 55,000 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-24 4 B $4.59 $3,925 D/D 850 54,200 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-23 4 B $4.28 $3,638 D/D 850 53,350 2.66     -
   Shirahama Norio Seijiro Vice President Asia Pacific   •       –      –    2006-08-23 4 B $4.17 $4,587 D/D 1,100 2,200 2.66     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-22 4 B $4.23 $6,997 D/D 1,617 52,500 2.74     -
   Shirahama Norio Seijiro Vice President Asia Pacific   •       –      –    2006-08-21 4 B $4.76 $5,236 D/D 1,100 1,100 2.74     -
   Saad Mark E Chief Financial Officer   •       –      –    2006-08-21 4 B $4.52 $3,991 D/D 883 50,883 2.66     -
   Olympus Corp 10% Owner   –       –       •   2006-08-09 4 B $5.75 $10,999,997 D/D 1,913,043 3,013,043 2.45     -
  340 Records found
  Previous  10  11  12  13  14   
  Page 11 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us